Role of Contractile Agonists in Growth Regulation of Vascular Smooth Muscle Cells

  • Gary K. Owens
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 308)


Accelerated smooth muscle growth is a characteristic feature in arteries of hypertensive patients and animals (1,15,26,27,36,40). In resistance vessels, this accelerated growth of smooth muscle contributes to development of medial thickening or hypertrophy and is thought to play an important role in the etiology of hypertension (1,13). It is hypothesized that medial hypertrophy confers a mechanical advantage such that at any given level of smooth muscle activation vascular resistance is greater in hypertensives than in controls (12,25). It should be noted, however, that medial hypertrophy does not appear to occur in very small arteries (< 100 gm internal diameter) and arterioles, but rather appears confined to large and intermediate sized resistance arteries (i.e. 150–300 gm internal diameter) (8,19,26,40). Extensive medial hypertrophy occurs in large conduit vessels, such as the aorta (33). In these vessels, medial hypertrophy is thought to be an adaptive process to minimize changes in wall stress that occur as a consequence of increases in blood pressure (34).


Smooth Muscle Cell Vascular Smooth Muscle Cell Arginine Vasopressin Cellular Hypertrophy Cultured Smooth Muscle Cell 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 61: 181–6, 1987.PubMedGoogle Scholar
  2. 2.
    Asaad M, Antonaccio M. Vascular wall renin in spontaneously hypertensive rats–potential relevance to hypertension maintenance and antihypertensive effect of captopril. Hypertension 4: 487–493, 1982.PubMedGoogle Scholar
  3. 3.
    Berk B, Alexander R, Brock T, Gimbrone M, Webb R. Vasoconstriction: A new activity for platelet-derived growth factor. Science 232: 87–90, 1986.PubMedCrossRefGoogle Scholar
  4. 4.
    Berk BC, Brock TA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MAJ, Alexander RW. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest 75: 1083–1086, 1985.PubMedCrossRefGoogle Scholar
  5. 5.
    Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13: 305–314, 1989.PubMedGoogle Scholar
  6. 6.
    Blaes N, Boissel J. Growth stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol 116: 167–172, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Blank R, Thompson M, Owens G. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic muscle cells. J Cell Biol 107: 299–306, 1988.PubMedCrossRefGoogle Scholar
  8. 8.
    Bohlen H, Lohach D. In vivo study of microvascular wall characteristics and resting control of young and mature spontaneously hypertensive rats. Blood Vessels 15: 322–330, 1978.Google Scholar
  9. 9.
    Campbell-Boswell M, Robertson A. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Expt Molec Path 35: 265–276, 1981.CrossRefGoogle Scholar
  10. 10.
    Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 89: 379–383, 1981.PubMedCrossRefGoogle Scholar
  11. 11.
    Corjay M, Lynch K, Thompson M, Owens G. Differential effect of PDGF versus serum induced growth on SM alpha actin and beta non-muscle actin mRNA expression in cultured rat aortic smooth muscle cells. J Biol Chem 264: 10501–10506, 1989.PubMedGoogle Scholar
  12. 12.
    Folkow B. Constriction-distension relationships of resistance vessels in normo-and hypertension. Clin Sci 57: 23s - 25s, 1979.PubMedGoogle Scholar
  13. 13.
    Folkow B. Physiological aspects of primary hypertension. Physiol Rev 62: 347–504, 1982.PubMedGoogle Scholar
  14. 14.
    Freslon J, Giudicelli J. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmac 80: 533–543, 1983.Google Scholar
  15. 15.
    Furuyama M. Histometrical investigations of arteries in reference to arterial hypertension. Toihoku J Exper Med 76: 388–414, 1962.CrossRefGoogle Scholar
  16. 16.
    Gabbiani GE, Rungger-Brandle DeChastonay C, Franke WW. Vimentin containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Invest 47: 265–269, 1982.PubMedGoogle Scholar
  17. 17.
    Geisterfer A, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res 62: 749–756, 1988.PubMedGoogle Scholar
  18. 18.
    Geisterfer A, Owens G. Arginine vasopressin induced hypertrophy of cultured rat aortic smooth muscle cells. Hypertension 14: 413–420, 1989.PubMedGoogle Scholar
  19. 19.
    Ichijima K. Morphological studies on the peripheral small arteries of spontaneously hypertensive rats. Jpn Circ J 33: 785–813, 1969.PubMedCrossRefGoogle Scholar
  20. 20.
    Kaczmarek L. Protooncogene expression during the cell cycle. Lab Invest 54: 365–76, 1986.PubMedGoogle Scholar
  21. 21.
    Kannel W, Doyle J, Ostfield A, Jenkins C, Kuller L. Podell R, Stamler J. Optimal resources for primary prevention of atherosclerotic diseases. Circ 70: 157A - 205A, 1984.CrossRefGoogle Scholar
  22. 22.
    Kawahara Y, Sunako M, Tsuda T, Fukuzaki H, Fukumoto Y, Takai Y. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 150: 52–9, 1988.PubMedCrossRefGoogle Scholar
  23. 23.
    Kocher O, Skalli O, Bloom W, Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells: Normal conditions and experimental intimal thickening. Lab Invest 50: 645–652, 1984.PubMedGoogle Scholar
  24. 24.
    Lichtenstein A, Brecher P, Chobanian A. Effects of hypertension and its reversal on the size and DNA content of rat aortic smooth muscle cells. Hypertension 8: 1150–1154, 1986.Google Scholar
  25. 25.
    Lopez RA, Mendoza SA, Nanberg E, Sinnett SJ, Rozengurt E. Cat+-mobilizing actions of platelet-derived growth factor differ from those of bombesin and vasopressin in Swiss 3T3 mouse cells. Proc Natl Acad Sci USA 84: 5768–72, 1987.CrossRefGoogle Scholar
  26. 26.
    Mulvany M, Baandrup U, Gundersen H. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res 57: 794–800, 1985.PubMedGoogle Scholar
  27. 27.
    Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 43: 854–864, 1978.PubMedGoogle Scholar
  28. 28.
    Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc Gene Expressions by angiotensin II in culture rat vascular smooth muscle cells. J Clin Invest 83: 1419 1424, 1989.Google Scholar
  29. 29.
    Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, Dzau VJ. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension 13: 706–11, 198.Google Scholar
  30. 30.
    Nemecek G, Coughlin S, Handley D, Moskowitz M. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83: 674–678, 1986.PubMedCrossRefGoogle Scholar
  31. 31.
    Owen NE. Effect of prostaglandin El on DNA synthesis in vascular smooth muscle cells. Am J Physiol 250: C584–588.Google Scholar
  32. 32.
    Owen N, Villereal M. Lys-bradykinin stimulates Na+ influx and DNA synthesis in cultured human fibroblasts. Cell 32: 979–985, 1983.PubMedCrossRefGoogle Scholar
  33. 33.
    Owens G. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol 26: H1755–1765, 1989.Google Scholar
  34. 34.
    Owens G. Differential effects of antihypertensive therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res 56: 525–536, 1985.PubMedGoogle Scholar
  35. 35.
    Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 9: 178–87, 1987.PubMedGoogle Scholar
  36. 36.
    Owens GK. Growth response of aortic smooth muscle cells in hypertension. In: Blood Vessel Changes in Hypertension: Structure and Function, M.K.W. Lee (ed.), Boca Raton: CRC Press, pp 45–63, 1989.Google Scholar
  37. 37.
    Owens G, Loeb A, Gordon D, Thompson M. Expression of smooth muscle specific alpha-isoactin in cultured vascular smooth muscle cells: Relationship between growth and cytodifferentiation. J Cell Biol 102: 343–352, 1986.PubMedCrossRefGoogle Scholar
  38. 38.
    Owens G, Rabinovitch P, Schwartz S. Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci USA 78: 7759–7763, 1981.PubMedCrossRefGoogle Scholar
  39. 39.
    Owens G, Schwartz S. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 51: 280–289, 1982.PubMedGoogle Scholar
  40. 40.
    Owens GK, Schwartz SM, McCanna M. Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats. Hypertension 11: 198–207, 1988.PubMedGoogle Scholar
  41. 41.
    Rovner A, Murphy R, Owens G. Expression of smooth muscle and non-muscle myosin heavy chains in cultured vascular smooth muscle cells. JBiol Chem 261: 14740–14745, 1986.Google Scholar
  42. 42.
    Rozengurt E. Early signals in the mitogenic response. Science 234: 161–166, 1986.PubMedCrossRefGoogle Scholar
  43. 43.
    Schwartz S, Ross R. Cellular proliferation in atherosclerosis and hypertension. Prog Cardiovasc Dis 26: 355–372, 1984.PubMedCrossRefGoogle Scholar
  44. 44.
    Scott BT, Resink TJ, Baur U, Burgin M, Buhler FR. Amiloride sensitive activation of S6 kinase by angiotensin II in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 151: 583–589, 1988.CrossRefGoogle Scholar
  45. 45.
    Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal GB. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Cat+ mobilization and protein kinase C activation. J Biol Chem 264: 526–530, 198.Google Scholar
  46. 46.
    Trippodo N, Frohlich E. Similarities of genetic (spontaneous) hypertension–man and rat. Circ Res 48: 309–319, 1981.PubMedGoogle Scholar
  47. 47.
    Turla M, Thompson M, Corjay M, Owens G. Angiotensin II and arginine vasopressin increase smooth muscle alpha-actin and nonmuscle beta-actin mRNA as well as actin synthesis and content in cultured rat aortic smooth muscle cells. J Cell Biol 109: 244a, 1989.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Gary K. Owens
    • 1
  1. 1.Department of PhysiologyUniversity of Virginia School of MedicineCharlottesvilleUSA

Personalised recommendations